304 related articles for article (PubMed ID: 16364933)
21. Effect of different regimens of gut decontamination on bacterial translocation and mortality in experimental acute pancreatitis.
Gianotti L; Munda R; Gennari R; Pyles R; Alexander JW
Eur J Surg; 1995 Feb; 161(2):85-92. PubMed ID: 7772636
[TBL] [Abstract][Full Text] [Related]
22. Role of nasogastric tube in preventing aspiration pneumonia in patients with dysphagia.
Mamun K; Lim J
Singapore Med J; 2005 Nov; 46(11):627-31. PubMed ID: 16228094
[TBL] [Abstract][Full Text] [Related]
23. The secretion severity rating scale: a potentially useful tool for management of acute-phase fasting stroke patients.
Ota K; Saitoh E; Baba M; Sonoda S
J Stroke Cerebrovasc Dis; 2011; 20(3):183-7. PubMed ID: 20621518
[TBL] [Abstract][Full Text] [Related]
24. Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial.
Oostdijk EAN; Kesecioglu J; Schultz MJ; Visser CE; de Jonge E; van Essen EHR; Bernards AT; Purmer I; Brimicombe R; Bergmans D; van Tiel F; Bosch FH; Mascini E; van Griethuysen A; Bindels A; Jansz A; van Steveninck FAL; van der Zwet WC; Fijen JW; Thijsen S; de Jong R; Oudbier J; Raben A; van der Vorm E; Koeman M; Rothbarth P; Rijkeboer A; Gruteke P; Hart-Sweet H; Peerbooms P; Winsser LJ; van Elsacker-Niele AW; Demmendaal K; Brandenburg A; de Smet AMGA; Bonten MJM
JAMA; 2014 Oct; 312(14):1429-1437. PubMed ID: 25271544
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial.
Kalra L; Irshad S; Hodsoll J; Simpson M; Gulliford M; Smithard D; Patel A; Rebollo-Mesa I;
Lancet; 2015 Nov; 386(10006):1835-44. PubMed ID: 26343840
[TBL] [Abstract][Full Text] [Related]
26. Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up.
Eveson DJ; Robinson TG; Potter JF
Am J Hypertens; 2007 Mar; 20(3):270-7. PubMed ID: 17324738
[TBL] [Abstract][Full Text] [Related]
27. Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract.
Karp JE; Merz WG; Hendricksen C; Laughon B; Redden T; Bamberger BJ; Bartlett JG; Saral R; Burke PJ
Scand J Infect Dis Suppl; 1986; 48():66-78. PubMed ID: 3535055
[TBL] [Abstract][Full Text] [Related]
28. Risk factors and outcome of dysphagia after an acute ischaemic stroke.
Hamidon BB; Nabil I; Raymond AA
Med J Malaysia; 2006 Dec; 61(5):553-7. PubMed ID: 17623955
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of multi-drug-resistant gram-negative bacteria: data from an university hospital over a 36-month period.
Vonberg RP; Wolter A; Chaberny IF; Kola A; Ziesing S; Suerbaum S; Gastmeier P
Int J Hyg Environ Health; 2008 Jul; 211(3-4):251-7. PubMed ID: 17980660
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. A randomized, double-blind, placebo-controlled, multicenter trial.
Sánchez García M; Cambronero Galache JA; López Diaz J; Cerdá Cerdá E; Rubio Blasco J; Gómez Aguinaga MA; Núnez Reiz A; Rogero Marín S; Onoro Canaveral JJ; Sacristán del Castillo JA
Am J Respir Crit Care Med; 1998 Sep; 158(3):908-16. PubMed ID: 9731025
[TBL] [Abstract][Full Text] [Related]
31. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
32. The natural history and clinical consequences of aspiration in acute stroke.
Kidd D; Lawson J; Nesbitt R; MacMahon J
QJM; 1995 Jun; 88(6):409-13. PubMed ID: 7648232
[TBL] [Abstract][Full Text] [Related]
33. Selective decontamination of the oropharynx and the digestive tract, and antimicrobial resistance: a 4 year ecological study in 38 intensive care units in the Netherlands.
Houben AJ; Oostdijk EA; van der Voort PH; Monen JC; Bonten MJ; van der Bij AK;
J Antimicrob Chemother; 2014 Mar; 69(3):797-804. PubMed ID: 24144922
[TBL] [Abstract][Full Text] [Related]
34. Reducing the dosing frequency of selective digestive tract decontamination to three times daily provides effective decontamination of Gram-negative bacteria.
de la Court JR; Sigaloff KCE; Groot T; van der Spoel JI; Schade RP
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1843-1850. PubMed ID: 33791891
[TBL] [Abstract][Full Text] [Related]
35. Prevention of infection in burns: preliminary experience with selective decontamination of the digestive tract in patients with extensive injuries.
Mackie DP; van Hertum WA; Schumburg T; Kuijper EC; Knape P
J Trauma; 1992 May; 32(5):570-5. PubMed ID: 1588644
[TBL] [Abstract][Full Text] [Related]
36. Impact of underlying diseases on the clinical characteristics and outcome of primary pyomyositis.
Chiu SK; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Aug; 41(4):286-93. PubMed ID: 18787734
[TBL] [Abstract][Full Text] [Related]
37. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
[TBL] [Abstract][Full Text] [Related]
38. Emergence of multidrug-resistant Gram-negative bacteria during selective decontamination of the digestive tract on an intensive care unit.
Al Naiemi N; Heddema ER; Bart A; de Jonge E; Vandenbroucke-Grauls CM; Savelkoul PH; Duim B
J Antimicrob Chemother; 2006 Oct; 58(4):853-6. PubMed ID: 16891326
[TBL] [Abstract][Full Text] [Related]
39. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
Abelson MB; Heller W; Shapiro AM; Si E; Hsu P; Bowman LM;
Am J Ophthalmol; 2008 Jun; 145(6):959-65. PubMed ID: 18374301
[TBL] [Abstract][Full Text] [Related]
40. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON).
Komisarof JA; Gilkey GM; Peters DM; Koudelka CW; Meyer MM; Smith SM
Crit Care Med; 2007 Feb; 35(2):435-41. PubMed ID: 17205018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
